{
    "clinical_study": {
        "@rank": "21649", 
        "arm_group": {
            "arm_group_label": "All participants"
        }, 
        "biospec_descr": {
            "textblock": "Blood sampling for biomarkers. A portion of each sample collected will be tested for five\n      different islet autoantibodies (presence and precise titers). The remaining portion of each\n      sample will be coded and then assessed for autoantibody isotypes, phenotyping of peripheral\n      blood mononuclear cells (PBMC), and profiling of cytokines, and pharmacogenetic markers."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study is conducted in the United States of America (USA). The aim of this study is to\n      assess longitudinal variation of immune biomarkers in subjects at risk for development of\n      type 1 diabetes (T1D)."
        }, 
        "brief_title": "An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes", 
            "Diabetes Mellitus, Type 1"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects with general good health as judged by the investigator\n\n          -  Participant tested positive at above or equal to 99th percentile for one or more of\n             three islet antibodies (GAD (glutamic acid decarboxylase), IA2 (islet antigen-2), IAA\n             (insulin autoantibody))\n\n        Exclusion Criteria:\n\n          -  Any chronic disorder (diabetes at enrolment) or severe disease which, in the opinion\n             of the investigator, might jeopardize subject's safety or compliance with the\n             protocol\n\n          -  Female of child-bearing potential who is pregnant, breast-feeding, or intends to\n             become pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "4 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who are at risk for developing T1D either by genetic testing or due to family\n        history and identified with one or more islet autoantibodies)."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01846312", 
            "org_study_id": "INS-4074", 
            "secondary_id": "U1111-1136-8383"
        }, 
        "intervention": {
            "arm_group_label": "All participants", 
            "description": "The participants will not receive any treatment.", 
            "intervention_name": "No treatment given", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "November 18, 2013", 
        "link": {
            "description": "Clinical Trials at Novo Nordisk", 
            "url": "http://novonordisk-trials.com"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Princeton", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "08540"
                }, 
                "name": "Novo Nordisk Clinical Trial Call Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "The Longitudinal Diabetes Biomarker Study: An Observational Study to Assess Longitudinal Variation of Immune Biomarkers in Subjects at Risk for Development of Type 1 Diabetes", 
        "overall_official": {
            "affiliation": "Novo Nordisk A/S", 
            "last_name": "Birgit Sehested Hansen", 
            "role": "Study Director"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Fluctuation in islet autoantibodies titers", 
            "safety_issue": "No", 
            "time_frame": "One-two years dependent on sampling frequency"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01846312"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Fluctuation in islet autoantibody isotypes", 
                "safety_issue": "No", 
                "time_frame": "One-two years dependent on sampling frequency"
            }, 
            {
                "measure": "Fluctuation in T-cell specificity profiling (mainly for CD8 (cluster of differentiation 8) T-cells)", 
                "safety_issue": "No", 
                "time_frame": "One-two years dependent on sampling frequency"
            }
        ], 
        "source": "Novo Nordisk A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Novo Nordisk A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}